Keep pulling the thread on Tom Hale.
In a study with UCSF involving 65,000 participants, Ōura detected biometric signatures of COVID-19 infection 2.75 days before a positive PCR test or diagnosis.
Ōura claims to possess the largest, most continuous, and most accurate dataset of women's health data in the world.
Ōura CEO Tom Hale predicts that large physiological models will eventually be able to forecast long-term health risks, such as a potential heart attack in 10 years, if a user does not change their behavior.
Since 2022, Ōura has grown to a reported valuation of $11 billion.
Ōura's mission is to help transform healthcare from a reactive "sick care system" to a proactive, preventative model.
In the United States, one out of every five dollars is spent on healthcare.
Measuring biometrics from the finger provides a more accurate signal than from the wrist because the arterial pulse wave stops at the fingertip, whereas the signal at the wrist is from returning capillary blood flow.
Ōura's "Readiness" score is calculated using resting heart rate, HRV balance, body temperature, recovery index, sleep, sleep balance, and sleep regularity.
Ōura has a feature called "Symptom Radar" that predicts the onset of illnesses based on shifts in a user's biometrics.
Ōura provides a pulse wave velocity metric, which serves as a proxy for arterial stiffness.
Ōura has a partnership with Natural Cycles, an FDA-cleared digital contraceptive application.
Ōura developed a proprietary, women-specific health model because it found that even frontier LLMs provided answers to women's health questions that were too generic or had an unempathetic tone.